The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...
The global prevalence and incidence of migraine significantly increased from 1990 to 2021, with faster growth rates predicted in men and adolescents through 2050.
A migraine is an intense headache that might be accompanied by other symptoms - but there are a few ways to tell the ...
8h
The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...
A nurse has shared seven different ways you can differentiate between a headache and a migraine. There are several telltale ...
When Pamela Hobbs started to suffer memory loss and became clumsy, she thought it was the menopause, but it turned out to be ...
For Roshelle, her diagnosis of migraine disease became the catalyst for a life of advocacy, empowerment, and community ...
However, Dr Nancy Foldvary-Schaefer, a sleep medicine physician and Director of the Sleep Disorders Center, told health ...
Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...
Sue Lilly has shared her experiences of 60 years of suffering with excruciating condition that nothing could touch – until now ...
In conversation with Dr Peter Goadsby, Director of NIHR Clinical Research Facility and Professor of Neurology at King's ...
Payton Harris was going to the doctor's office for a routine health screening when they were met with unexpected news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback